Corpus ID: 13312163

Use of natural products to treat benign prostatic hyperplasia ( BPH ) and chronic non-bacterial prostatitis : emphasis on Cernitin ®

@inproceedings{Preuss2012UseON,
  title={Use of natural products to treat benign prostatic hyperplasia ( BPH ) and chronic non-bacterial prostatitis : emphasis on Cernitin ®},
  author={Harry G. Preuss},
  year={2012}
}
  • Harry G. Preuss
  • Published 2012
    • Many males throughout the world, both young and old, suffer severely from the ravages of cardiovascular disorders and cancers, but another important area of specific concern receiving less attention involves a small gland of the reproductive tract called the prostate [1]. The prostate is very important for a number of health reasons. Malignancy of this gland is recognized as the most common cancer among men (1 out of 10) and, unfortunately, is the second most fatal. It has been estimated that… CONTINUE READING
    graminex.com

    References

    SHOWING 1-10 OF 41 REFERENCES
    Benign prostatic hyperplasia: A review of its histogenesis and natural history
    • 129
    The economics of benign prostatic hyperplasia treatment: a literature review.
    • 46
    The extract of Serenoa repens in the treatment of benign prostatic hyperplasia: A multicenter open study
    • 76
    Flower Pollen Extract and its Effect on the Prostate A preliminary investigation on the therapeutic effect of Cernilton in chronic prostatovesiculitis
    • 9
    • Highly Influential
    • PDF
    Editorial Review of Treatment of Benign Prostatic Hyperplasia
    • 3
    Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH)
    • 36
    • PDF
    Quantitative Evaluation on the Effectiveness of Cernilton ® on Benign Prostatic Hypertrophy
    • 9
    • PDF
    A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy.
    • 223
    Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.
    • 111
    The development of human benign prostatic hyperplasia with age.
    • 1,919